Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Yosuke Yoshida
Masayuki Kaneko
Mamoru Narukawa
机构：
[1] Kitasato University,Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences
[2] MSD K.K.,undefined
[3] a subsidiary of Merck & Co.,undefined
[4] Inc,undefined
来源：
Pharmaceutical Medicine | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 92
页数：11
相关论文
共 50 条
  • [1] Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung Cancer
    Yoshida, Yosuke
    Kaneko, Masayuki
    Narukawa, Mamoru
    [J]. PHARMACEUTICAL MEDICINE, 2021, 35 (02) : 81 - 92
  • [2] Correlation between progression-free and overall survival in a meta-analysis of aggregated survival data from patients with non-small cell lung cancer
    Aksenov, Sergey
    Lee, Daniel
    Edlund, Helena
    Minchella, Kaitlyn
    Xu, Hongmei
    Dunyak, James
    Al-Huniti, Nidal
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S63 - S64
  • [3] Meta-analysis of progression-free survival as a predictor of overall survival in locally advanced or metastatic non-small cell lung cancer trials.
    Turner, Evadne Jane
    McCloud, Philip
    Germanos, Peter
    Dehle, Francis
    Norris, Sarah
    Tan, Jonathan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
    Lee, Chee Khoon
    Brown, Chris
    Gralla, Richard J.
    Hirsh, Vera
    Thongprasert, Sumitra
    Tsai, Chun-Ming
    Tan, Eng Huat
    Ho, James Chung-Man
    Chu, Da Tong
    Zaatar, Adel
    Osorio Sanchez, Jemela Anne
    Vu Van Vu
    Au, Joseph Siu Kie
    Inoue, Akira
    Lee, Siow Ming
    Gebski, Val
    Yang, James Chih-Hsin
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (09) : 595 - 605
  • [5] Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
    Masayuki Aboshi
    Masayuki Kaneko
    Mamoru Narukawa
    [J]. Journal of Cancer Research and Clinical Oncology, 2014, 140 : 839 - 848
  • [6] Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
    Aboshi, Masayuki
    Kaneko, Masayuki
    Narukawa, Mamoru
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (05) : 839 - 848
  • [7] Overall response rate as a surrogate of progression-free survival with molecular targeted agents: A meta-analysis of phase III trials in advanced non-small cell lung cancer.
    Akamatsu, Hiroaki
    Mori, Keita
    Kikuchi, Takashi
    Ueda, Hiroki
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Koh, Yasuhiro
    Matsunaga, Kazuto
    Yamamoto, Nobuyuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] META-ANALYSIS OF PROGRESSION-FREE SURVIVAL AND OBJECTIVE RESPONSE RATE AS PREDICTORS OF OVERALL SURVIVAL IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
    Turner, Evadne J.
    Mccloud, Philip
    Germanos, Peter
    Dehle, Francis
    Norris, Sarah
    Tan, Jonathon
    Mitchell, Paul L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S243 - S244
  • [9] Anlotinib as treatment for advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival and progression free survival
    Susanto, B.
    Marcella, E.
    Chen, S.
    Heriyanto, R. S.
    Tandiono, J.
    Wijovi, F.
    Tancherla, A.
    Kurniawan, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S792 - S792
  • [10] Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
    Paoletti, Xavier
    Oba, Koji
    Bang, Yung-Jue
    Bleiberg, Harry
    Boku, Narikazu
    Bouche, Olivier
    Catalano, Paul
    Fuse, Nozomu
    Michiels, Stefan
    Moehler, Markus
    Morita, Satoshi
    Ohashi, Yasuo
    Ohtsu, Atsushi
    Roth, Arnaud
    Rougier, Philippe
    Sakamoto, Junichi
    Sargent, Daniel
    Sasako, Mitsuru
    Shitara, Kohei
    Thuss-Patience, Peter
    Van Cutsem, Eric
    Burzykowski, Tomasz
    Buyse, Marc
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (21) : 1667 - 1670
12345